Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
Posted on Sunday, July 1, 2007 - 09:16, By: Margaret Wahl
The announcement this spring that yet another promising drug had failed to help people with ALS in a clinical trial has led some in the field to re-examine some assumptions.
Minocycline, an antibiotic with anti-inflammatory and anti-cell death properties, had shown positive effects in ALS-...